Other urinary lncRNAs have been proposed alone or in combination to determine their diagnostic utility in bladder cancer, such as TERC (24), the twosome MIR205HG-GAS5 (25), and the 3-lncRNA panels MALAT1, PCAT-1, and SPRY4IT1 (26), which exhibited good differentiating ability between healthy and diseased subjects. This evidence concerns the gene PCAT1 and urinary bladder cancer.